National Finance Company SAOG (MSM:NFCI)

Sage Therapeutics Income Statement

Financials in millions OMR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY	FY 2023	FY	FY 2022
Period Ending	Jun 30, 2025	Dec 31, 2024	Mar 31, 2024	Dec 31, 2023	Mar 31, 2023	Dec 31, 2022
Interest and Dividend Income	66.88	60.47	-	48.91	-	43.49
Total Interest Expense	29.08	29.08	-	23.06	-	17.99
Net Interest Income	37.8	31.39	-	25.85	-	25.5
Other Revenue	2.81	2.81	-	2.52	-	2.63
Revenue Before Loan Losses	40.61	34.2	-	28.36	-	28.12
Provision for Loan Losses	4.65	4.65	-	2.06	-	4.07
Revenue	35.96	29.55	-	26.3	-	24.05
Revenue Growth (YoY)	29.24%	-	-	-	-	17.81%
Salaries & Employee Benefits	10.49	10.49	-	9.03	-	7.76
Cost of Services Provided	4.27	1.84	-	1.62	-	1.97
Other Operating Expenses	4.58	1.76	-	1.66	-	1.59
Total Operating Expenses	20.55	15.3	-	13.24	-	12.22
Operating Income	15.41	14.25	-	13.07	-	11.83
EBT Excluding Unusual Items	15.41	14.25	-	13.07	-	11.83
Pretax Income	15.41	14.25	-	13.07	-	11.92
Income Tax Expense	2.14	2.14	-	1.96	-	1.79
Net Income	13.28	12.11	-	11.11	-	10.13
Preferred Dividends & Other Adjustments	1.36	1.36	-	0.72	-	1.46
Net Income to Common	11.92	10.75	-	10.38	-	8.68
Net Income Growth	14.89%	-	-	-	-	17.54%
Shares Outstanding (Basic)	608	608	-	608	-	608
Shares Outstanding (Diluted)	608	608	-	608	-	608
Shares Change (YoY)	-0.91%	-	-	-	-	-
EPS (Basic)	0.02	0.02	-	0.02	-	0.01
EPS (Diluted)	0.02	0.02	-	0.02	-	0.01
EPS Growth	8.51%	-	-	-	-	22.41%
Free Cash Flow	-	-26.02	-	23.07	-	6.05
Free Cash Flow Per Share	-	-0.04	-	0.04	-	0.01
Dividend Per Share	-	0.012	-	0.009	-	0.007
Operating Margin	42.85%	48.21%	-	49.68%	-	49.18%
Profit Margin	33.13%	36.39%	-	39.48%	-	36.08%
Free Cash Flow Margin	-	-88.06%	-	87.70%	-	25.15%
Effective Tax Rate	13.87%	14.99%	-	15.02%	-	15.00%

Source: S&P Global Market Intelligence. Financial Services template. Financial Sources.